POP MART
09992
XIAOMI-W
01810
BYD COMPANY
01211
4
BABA-W
09988
5
HORIZONROBOT-W
09660
HK Stock MarketDetailed Quotes
09997 KANGJI MEDICAL
- 7.530
- +0.030+0.40%
Market Closed May 2 16:08 CST
9.10BMarket Cap14.51P/E (TTM)
7.800High7.240Low671.00KVolume7.800Open7.500Pre Close4.97MTurnover0.06%Turnover Ratio14.51P/E (Static)1.21BShares8.82052wk High3.21P/B9.10BFloat Cap4.91052wk Low1.55Dividend TTM1.21BShs Float33.690Historical High1.546Dividend LFY7.47%Amplitude3.537Historical Low7.412Avg Price500Lot Size20.53%Div YieldTTM20.53%Div Yield LFY
KANGJI MEDICAL Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8.92%1.01B | 13.58%458.41M | 17.76%926.02M | 21.45%403.59M | 13.92%786.37M | 4.46%332.32M | 34.95%690.26M | 49.64%318.12M | 1.59%511.49M | --212.59M |
| Operating income | 8.92%1.01B | 13.58%458.41M | 17.76%926.02M | 21.45%403.59M | 13.92%786.37M | 4.46%332.32M | 34.95%690.26M | 49.64%318.12M | 1.59%511.49M | 212.59M |
| Cost of sales | -14.14%-210.96M | -16.44%-95.29M | -22.30%-184.82M | -22.86%-81.83M | -18.68%-151.12M | -17.07%-66.61M | -59.13%-127.34M | -62.78%-56.9M | 0.34%-80.02M | ---34.95M |
| Operating expenses | -14.14%-210.96M | -16.44%-95.29M | -22.30%-184.82M | -22.86%-81.83M | -18.68%-151.12M | -17.07%-66.61M | -59.13%-127.34M | -62.78%-56.9M | 0.34%-80.02M | -34.95M |
| Gross profit | 7.62%797.65M | 12.86%363.12M | 16.68%741.2M | 21.09%321.76M | 12.85%635.25M | 1.72%265.71M | 30.47%562.93M | 47.06%261.23M | 1.96%431.47M | 177.63M |
| Selling expenses | -11.96%-78.2M | -20.00%-39.06M | -30.86%-69.84M | -36.24%-32.55M | -14.74%-53.37M | -13.73%-23.89M | 4.87%-46.52M | 9.48%-21.01M | -18.23%-48.89M | ---23.21M |
| Administrative expenses | 2.93%-97.33M | -11.97%-50.85M | -40.69%-100.27M | -37.63%-45.42M | -14.84%-71.27M | -28.26%-33M | 20.44%-62.06M | 52.36%-25.73M | -204.16%-78M | ---54M |
| Research and development expenses | 35.65%-82.08M | 27.83%-43.35M | -93.21%-127.55M | -128.60%-60.08M | -83.38%-66.02M | -63.49%-26.28M | -42.75%-36M | -33.11%-16.07M | -45.13%-25.22M | ---12.08M |
| Impairment and provision | 126.22%279K | 151.12%842K | -200.95%-1.06M | -157.75%-1.65M | 271.66%1.05M | ---639K | ---614K | ---- | ---- | ---- |
| -Other impairment is provision | 126.22%279K | 151.12%842K | -200.95%-1.06M | -157.75%-1.65M | 271.66%1.05M | ---639K | ---614K | ---- | ---- | ---- |
| Special items of operating profit | 12.42%167.02M | 14.52%103.52M | 24.44%148.56M | 564.33%90.4M | 2.07%119.38M | -62.24%13.61M | 280.19%116.96M | 40.96%36.04M | -41.29%30.76M | --25.57M |
| Operating profit | 19.68%707.33M | 22.67%334.22M | 4.60%591.03M | 39.36%272.46M | 5.67%565.02M | -16.61%195.51M | 72.42%534.69M | 105.82%234.46M | -20.73%310.12M | 113.92M |
| Financing cost | 71.82%-636K | 47.83%-614K | -20.37%-2.26M | -64.62%-1.18M | -856.63%-1.88M | -568.22%-715K | -366.67%-196K | ---107K | ---42K | ---- |
| Share of profits of associates | ---21.86M | ---5.87M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 16.32%684.83M | 20.81%327.73M | 4.55%588.77M | 39.27%271.28M | 5.36%563.14M | -16.88%194.79M | 72.38%534.5M | 105.72%234.35M | -20.74%310.08M | 113.92M |
| Tax | 16.79%-113.56M | -23.97%-52.05M | -33.84%-136.48M | -1.67%-41.99M | -31.22%-101.97M | -18.02%-41.3M | -52.59%-77.71M | -43.88%-34.99M | 21.00%-50.93M | ---24.32M |
| After-tax profit from continuing operations | 26.31%571.28M | 20.23%275.69M | -1.93%452.3M | 49.38%229.3M | 0.96%461.17M | -23.00%153.5M | 76.26%456.79M | 122.51%199.36M | -20.68%259.15M | 89.6M |
| Earning after tax | 26.31%571.28M | 20.23%275.69M | -1.93%452.3M | 49.38%229.3M | 0.96%461.17M | -23.00%153.5M | 76.26%456.79M | 122.51%199.36M | -20.68%259.15M | 89.6M |
| Minority profit | 80.36%-10.16M | 61.16%-10.16M | -194.55%-51.73M | -520.59%-26.16M | ---17.56M | ---4.22M | ---- | ---- | -92.64%8.85M | --8.85M |
| Profit attributable to shareholders | 15.36%581.44M | 11.89%285.85M | 5.28%504.02M | 61.98%255.46M | 4.80%478.74M | -20.89%157.71M | 82.50%456.79M | 146.91%199.36M | 21.24%250.3M | 80.74M |
| Basic earnings per share | 14.79%0.4945 | 11.73%0.2439 | 8.71%0.4308 | 68.57%0.2183 | 6.22%0.3963 | -20.41%0.1295 | 42.03%0.3731 | 36.49%0.1627 | 30.63%0.2627 | 0.1192 |
| Diluted earnings per share | 15.03%0.4945 | 12.24%0.2439 | 8.48%0.4299 | 67.80%0.2173 | 6.88%0.3963 | -19.76%0.1295 | 42.78%0.3708 | 36.55%0.1614 | 29.14%0.2597 | 0.1182 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.